CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Magstim SuperRapiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01512264
NCT01512264N/ACompleted
CompareCT.gov

Post-Stroke Aphasia and rTMS Treatment Study (PART)

University of Alabama at Birmingham·interventional·Posted Jan 19, 2012·Updated Jul 14, 2020

In Brief

A clinical study evaluating Magstim SuperRapid for Aphasia and Stroke. Completed, enrolled 28 participants across 1 site.

Detailed Summary

In this study the investigators will examine the efficacy of navigated excitatory repetitive transcranial magnetic stimulation (nerTMS) for the treatment of post stroke aphasia. The investigators expect that this new types of rehabilitation (nerTMS) will help patients with aphasia return to their lives as they were prior to the stroke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphasia, Stroke
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD)

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 19, 2012
Enrollment StartJan 1, 2012
Primary CompletionJul 20, 2018
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 14.5 years ago

Interventions

Magstim SuperRapiddevice

This design will allow systematic evaluation of the efficacy of nerTMS and its most optimal dose for language recovery.